The U.S. National Institutes of Health counts 135 registered trials of curcumin in the last 15 years, according to the study authors, but not one double - blind, placebo - controlled clinical
trial on curcumin can support all of the benefits we've been attributing to it, and when it comes to research that seemed to prove curcumin's effects on pancreatic and colon cancers, Alzheimer's disease, and radiation - induced rashes, it seems that the supposed benefits are all cracked up.
Not exact matches
Although a considerable body of scientific evidence substantiates the positive correlation between
curcumin consumption and a reduction in the risk of cancer, the paucity of suitably designed human clinical
trials that clearly demonstrate any direct effect of
curcumin on cancer markers may prevent Health Canada from approving a cancer risk reduction claim for
curcumin within the current regulatory framework.
A double - blind randomised - controlled crossover
trial was designed to measure the effects of oral
curcumin versus placebo
on single - leg jump performance and DOMS following unaccustomed heavy eccentric exercise.
As of June 2015, there were 116 clinical
trials evaluating the possible anti-disease effect of
curcumin in humans, including studies
on cancer, gastrointestinal diseases, cognitive disorders, and psychiatric conditions.
To test the theory, a
trial was carried out to measure the effects of oral
curcumin versus placebo
on DOMS following unaccustomed heavy eccentric exercise.
(2015) An investigation of the effects of
curcumin on anxiety and depression in obese individuals: A randomized controlled
trial.
In a recent
trial for ulcerative colitis, a multicenter, randomized, placebo - controlled, double - blind study found that more than 50 percent of patients achieved remission within just one month
on curcumin compared to none of the patients who received the placebo.
When it comes to human
trials, a clinical study
on 44 male smokers with lesions in the colon found that the subjects who took 4 grams of
curcumin per day for 30 days reduced their number of lesions by 40 %.